Patent · US Active

Pterostilbene cocrystals

US8415507B2 · kind B2 · utility

11Cited by

0References

23Claims

0Family size

Assignee

LAURUS LABS LIMITED · IN

Inventors

Nathan Carl Schultheiss · Kingwood, US
Sarah Bethune · Durham, US

Key dates

Filing date	Jul 30, 2010
Grant date	Apr 9, 2013
Priority date	—
Expiry date	Aug 4, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C43/23
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Cocrystals of pterostilbene are disclosed, including: pterostilbene:caffeine cocrystal, pterostilbene:carbamazepine cocrystal, pterostilbene:glutaric acid cocrystal, and pterostilbene:piperazine cocrystal. The pterostilbene:caffeine cocrystal is polymorphic. Forms I and II of the pterostilbene:caffeine cocrystal are disclosed. The therapeutic uses of the pterostilbene cocrystals and of pharmaceutical/nutraceutical compositions containing them are also disclosed. The disclosure sets out various methods of making and characterizing the pterostilbene cocrystals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.